Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
European Journal of Haematology
|
September 3, 2011
Reply to the letter to the editor by Guinn et al
Josef Karban, Heidi Mocikova, Robert Pytlik, et al.
Leukemia & Lymphoma
|
April 7, 2012
Rituximab-induced coagulopathy
Jan Novak, Heidi Mocikova, Petr Pavlicek, et al.
Leukemia & Lymphoma
|
January 15, 2013
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma
Monika Palickova, Heidi Mocikova, Zdenka Vernerova, et al.
Annals of Hematology
|
September 8, 2022
Circulating tumor DNA in Hodgkin lymphoma
Maria Maco, Kristyna Kupcova, Vaclav Herman, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 29, 2008
Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET)
Frantisek Bednar, Pavel Osmancik, Tomas Vanek, et al.
Expert Review of Molecular Diagnostics
|
May 6, 2025
Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas
Iva Hamova, Maria Maco, Anton Tkachenko, et al.
Leukemia Research
|
May 7, 2011
No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma
Ondrej Havranek, Martin Spacek, Petr Hubacek, et al.
Acta Haematologica
|
May 30, 2015
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
Heidi Mocikova, Robert Pytlik, Pavla Stepankova, et al.
Leukemia & Lymphoma
|
April 19, 2016
Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry
Heidi Mocikova, Robert Pytlik, Alice Sykorova, et al.
Leukemia & Lymphoma
|
August 4, 2017
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma
Wojciech Jurczak, Sundra Ramanathan, Pratyush Giri, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
European Journal of Haematology
|
September 3, 2011
Reply to the letter to the editor by Guinn et al
Josef Karban, Heidi Mocikova, Robert Pytlik, et al.
Leukemia & Lymphoma
|
April 7, 2012
Rituximab-induced coagulopathy
Jan Novak, Heidi Mocikova, Petr Pavlicek, et al.
Leukemia & Lymphoma
|
January 15, 2013
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma
Monika Palickova, Heidi Mocikova, Zdenka Vernerova, et al.
Annals of Hematology
|
September 8, 2022
Circulating tumor DNA in Hodgkin lymphoma
Maria Maco, Kristyna Kupcova, Vaclav Herman, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 29, 2008
Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET)
Frantisek Bednar, Pavel Osmancik, Tomas Vanek, et al.
Expert Review of Molecular Diagnostics
|
May 6, 2025
Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas
Iva Hamova, Maria Maco, Anton Tkachenko, et al.
Leukemia Research
|
May 7, 2011
No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma
Ondrej Havranek, Martin Spacek, Petr Hubacek, et al.
Acta Haematologica
|
May 30, 2015
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
Heidi Mocikova, Robert Pytlik, Pavla Stepankova, et al.
Leukemia & Lymphoma
|
April 19, 2016
Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry
Heidi Mocikova, Robert Pytlik, Alice Sykorova, et al.
Leukemia & Lymphoma
|
August 4, 2017
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma
Wojciech Jurczak, Sundra Ramanathan, Pratyush Giri, et al.
Page
of 4